Mankind Pharma has received a GST order related to its previously merged subsidiary, Lifestar Pharma Private Limited, for financial years 2018-19 and 2019-20. The order, issued by the Assistant Commissioner, Cuttack, imposes a penalty of INR 22,16,148. Mankind Pharma intends to appeal the order, considering it unjustified. The company anticipates no material impact on financials or operations.
GST Order Details
Mankind Pharma has received an order on November 15, 2025, from the Assistant Commissioner, Cuttack, regarding GST obligations. The order pertains to the financial years 2018-19 and 2019-20 of Lifestar Pharma Private Limited, a wholly-owned subsidiary that has since merged with Mankind Pharma.
Penalty Imposed
The order imposes a penalty of INR 22,16,148 on the former Lifestar Pharma Private Limited. This penalty arises from the alleged non-compliance with provisions under the CGST Act, SGST Act, and IGST Act.
Company’s Response
Mankind Pharma believes the order is arbitrary and unjustified based on its assessment of the facts and prevailing law. The company plans to appeal the order with the appropriate appellate authority. The company expects that there will be no material impact on its financials, operations, or other activities as a result of this order.
Alleged Violation Details
The order contends that there has been an alleged mismatch in the Input Tax Credit (ITC) figures reported in the GST return. Mankind Pharma disagrees with the order.
Source: BSE
